Research Appraisalobservational

Long Covid and Digital Health in Switzerland: Potentials and Limitations

Studies in health technology and informaticsKaufmann, Beatrice, Hess, Gabriel, Cvijic, Lana et al.21 May 2026DOI

Clinical Snapshot

65CEBM
Evidence: Moderateobservational

PICO Framework

P — PopulationIndividuals with Long Covid/Post-COVID-19 condition in Switzerland
I — InterventionDigital health interventions (DHIs) including mobile applications and digital tools
C — ComparatorNo specific comparator - descriptive assessment study
O — OutcomesQuality assessment across usability, practical usefulness, accessibility, and data protection using 19-item framework

Bottom Line

This Swiss study evaluated 10 Long Covid digital health interventions using a validated 19-item framework, finding reasonable usability (79%) but concerning gaps in accessibility (46%) and data protection (58%). The discontinuation of several Swiss apps during the study highlights market instability. While the methodology is sound with multiple reviewers and consensus ratings, the small sample and unclear selection criteria limit generalisability. For Australian clinicians, this suggests caution when recommending Long Covid apps to patients, particularly regarding accessibility for diverse populations and data privacy. The study reinforces the need for regulatory oversight and quality standards for health apps, similar to TGA's emerging digital therapeutics framework. Healthcare providers should prioritise apps with demonstrated accessibility features and transparent data practices when supporting Long Covid patients with digital tools.

Evidence: Moderate

Key Findings

  • P Value: Not applicable - descriptive study

  • Effect Size: Total quality scores ranged from 14.7 to 26.3 out of 38 possible points

  • Primary Outcome: Quality assessment scores across five categories for Long Covid digital health interventions

  • Nnt Or Sensitivity: Usability: 6.3/8 (79%), Practical usefulness: 5/8 (63%), Accessibility: 3.7/8 (46%), Data protection: 4.6/8 (58%)

  • Confidence Interval: Not reported

Clinical Application

Moderate - highlights need for quality standards and institutional support for sustainable DHI implementation Limited direct applicability due to different regulatory environment (TGA vs Swiss), but methodology could inform Australian DHI evaluation. Accessibility concerns particularly relevant given Australian disability standards Healthcare providers and patients managing Long Covid symptoms seeking digital health solutions

Abstract

Post-COVID-19 (or Long Covid) presents a complex and persistent health challenge affecting a growing number of individuals worldwide. Digital health interventions (DHIs) offer potential support for symptom monitoring, self-management, and information access. However, their availability, quality, and sustainability remain uncertain, particularly in smaller healthcare markets such as Switzerland. This study provides a descriptive assessment of ten representative DHIs for Long Covid available from Switzerland. Each tool was evaluated using a 19-item framework derived from validated instruments. Three independent reviewers tested all interventions on iOS and Android devices, with consensus ratings across five quality categories. Results showed strong usability (average 6.3/8) and practical usefulness (5/8), but consistent weaknesses in accessibility (3.7/8) and data protection (4.6/8). Total scores ranged from 14.7 to 26.3 out of 38. Several Swiss-based apps were discontinued during the study period, highlighting market fragility. Findings underscore the need for inclusive design, transparent data practices, and institutional support if DHIs are to complement Long Covid care sustainably.

References

  1. 1.Kaufmann, B., Hess, G., Cvijic, L., & Denecke, K. (2026). Long Covid and Digital Health in Switzerland: Potentials and Limitations. Studies in Health Technology and Informatics. https://doi.org/10.3233/SHTI260677
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service